{
  "prompt": {
    "guidelineId": "mp002-fetal-anomaly-screening-programme-sr-sept-pdf",
    "fieldsProcessed": [
      "humanFriendlyName",
      "organisation",
      "yearProduced",
      "summary"
    ],
    "enhancedFields": 4,
    "contentLength": 13028
  },
  "response": "{\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Fetal Anomaly Screening Guidelines for Down’s, Edwards’, and Patau’s Syndromes\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"NHS\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"2009\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Fetal Anomaly Screening Programme Guidelines:** - **Screening Offer:** All pregnant individuals should be offered screening for Down’s (T21), Edwards’ (T18), and Patau’s (T13) syndromes. - **Tests Available:** - *Combined test* (first trimester) screens for T21, T18/T13, or all three. - *Quadruple test* (14+2 to 20+0 weeks) screens for T21 only. - **Informed Choice:** Pre-test information must be provided, with interpreters for non-English speakers. Choices (including declining screening) must be documented. - **Process:** - NT scans and blood tests are performed per protocol. - Results categorized as *low chance* (communicated via letter within 2 weeks) or *high chance* (direct contact by midwife within 1 working day). - **High-Chance Results:** Offer follow-up within 3 days, including diagnostic testing (amniocentesis/NIPT) with counseling on miscarriage risk. - **Increased NT (>3.5mm):** Requires fetal cardiac scan and anomaly scan; offer combined screening and invasive testing. - **Anomaly Detection:** Refer to fetal medicine/specialist teams; document all discussions and decisions. - **Audit:** Annual reporting on test coverage, turnaround times, and performance. - **Staff:** Ensure training, interpreter use, and failsafe checks (e.g., weekly database reviews for missing results). *Emphasis on patient autonomy, clear communication, and timely follow-up.* (199 words)\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "endpoint": "enhanceGuidelineMetadata",
  "timestamp": "2025-06-18T22-31-20",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"guidelineId\": \"mp002-fetal-anomaly-screening-programme-sr-sept-pdf\",\n  \"fieldsProcessed\": [\n    \"humanFriendlyName\",\n    \"organisation\",\n    \"yearProduced\",\n    \"summary\"\n  ],\n  \"enhancedFields\": 4,\n  \"contentLength\": 13028\n}\n\nA: {\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Fetal Anomaly Screening Guidelines for Down’s, Edwards’, and Patau’s Syndromes\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"NHS\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"2009\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Fetal Anomaly Screening Programme Guidelines:** - **Screening Offer:** All pregnant individuals should be offered screening for Down’s (T21), Edwards’ (T18), and Patau’s (T13) syndromes. - **Tests Available:** - *Combined test* (first trimester) screens for T21, T18/T13, or all three. - *Quadruple test* (14+2 to 20+0 weeks) screens for T21 only. - **Informed Choice:** Pre-test information must be provided, with interpreters for non-English speakers. Choices (including declining screening) must be documented. - **Process:** - NT scans and blood tests are performed per protocol. - Results categorized as *low chance* (communicated via letter within 2 weeks) or *high chance* (direct contact by midwife within 1 working day). - **High-Chance Results:** Offer follow-up within 3 days, including diagnostic testing (amniocentesis/NIPT) with counseling on miscarriage risk. - **Increased NT (>3.5mm):** Requires fetal cardiac scan and anomaly scan; offer combined screening and invasive testing. - **Anomaly Detection:** Refer to fetal medicine/specialist teams; document all discussions and decisions. - **Audit:** Annual reporting on test coverage, turnaround times, and performance. - **Staff:** Ensure training, interpreter use, and failsafe checks (e.g., weekly database reviews for missing results). *Emphasis on patient autonomy, clear communication, and timely follow-up.* (199 words)\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}